Releaf

What Releaf does

Releaf is a private, UK-headquartered digital medical cannabis clinic group operating in the United Kingdom and Germany under the entities Releaf Dispensary Ltd and Releaf DE GmbH (Neuss). The company delivers an end-to-end telemedicine workflow: patients select products from a curated 50+ strain catalogue, complete a 15-question medical questionnaire without a required video consultation, receive physician review and prescription issuance, and have medication dispatched by licensed partner pharmacies (Grafenberger Apotheke in Düsseldorf, Apotheke am Bahnhof in Speyer) with same-day courier in seven major German cities and 1–3 day standard delivery elsewhere. Its platform is differentiated by an AI-powered strain search tool, ISO 27001 and ISO 9001 certifications, and a no-subscription, no-monthly-fee pricing model (€5.99 prescription fee plus per-gram product pricing in Germany; UK private clinic pricing not publicly disclosed).

Releaf's business model is fee-for-service and direct-to-consumer e-commerce. In Germany, the company monetises per prescription plus per-gram flower sales, with checkout supporting Klarna, Apple Pay, Google Pay, Visa, Mastercard, Amex, PayPal, and SEPA. In the UK, it operates a private clinic serving 220,000+ patients cumulatively, complemented by ancillary services such as the 2026-launched Releaf Protect 24/7 legal support offering in partnership with UK law firm Irwin Mitchell and the Releaf Cannabis Card for portable prescription verification. The customer base is diversified across multiple therapeutic verticals — chronic pain (73% of prescriptions, the primary use case), mental health, sleep disorders, neurology, gynecology, gastroenterology, and oncology — and the company maintains an active content, SEO, paid media, and PR engine to sustain patient acquisition.

The company was founded in 2022, expanded into Germany in 2024 following Germany's CanG reform, and raised a $6.75M funding round in 2024. It employs 101–250 staff across medical, executive, patient support, triage, marketing, finance, and HR functions, with a named C-suite (CEO Tim Kirby, CTO Oliver Soar, CFO Scott Stephen, COO Graham Woodward, CLO Rupa Shah) and a Medical Director. Partnerships span product supply (Aurora via the Pedanios line, Cannamedical), pharmacy dispensing (Grafenberger Apotheke, Apotheke am Bahnhof), and patient legal services (Irwin Mitchell). Ownership composition, founder equity, and detailed financials are not disclosed in the source material.

Name

Releaf

Legal name

Releaf DE GmbH

Website

https://releaf.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Releaf is a UK-headquartered digital medical cannabis clinic operating in the United Kingdom and Germany, serving over 200,000 patients with online consultations, AI-assisted strain matching, prescription issuance, and pharmacy-fulfilled delivery of medical cannabis flower.

Ownership category

akta.pro rank

Product category

Medical Cannabis Telehealth

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Medical Cannabis Dispensaries (CRANAFAB)

akta.pro secondary industry

Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

Keywords

• Medical cannabis clinic
• Telemedicine prescriptions
• Cannabis patient care
• Pharmacy fulfillment services
• Online healthcare platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Prescription fee + product sales (Germany): Patients pay a flat €5.99 per prescription (Rx fee) plus per-gram product pricing (e.g., 10g packs ranging from ~€47 to ~€121) for medical cannabis flower, fulfilled via partner German pharmacies. No subscriptions, no monthly fees, no minimum terms.
2. Direct medical cannabis e-commerce: Releaf's own e-commerce storefront enables direct unit-priced purchases of medical cannabis, with checkout supported by Klarna, Apple Pay, Google Pay, Visa, Mastercard, Amex, PayPal and SEPA.
3. Private medical cannabis clinic services (UK): Fee-for-service private clinic revenue from over 220,000 UK patients accessing digital consultations, prescriptions and medication, with structured patient pathways and additional services such as the "Releaf Protect" 24/7 legal support service.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Releaf is a private medical cannabis clinic group operating in the UK and Germany that delivers online specialist consultations, physician-issued prescriptions, and direct-to-patient pharmacy fulfillment of 50+ medical cannabis flower strains via a proprietary digital health platform with AI-assisted strain matching. Patients complete a 15-question medical questionnaire (no video call required), receive a prescription (€5.99 flat fee in Germany) and have medication delivered same-day or next-day from licensed partner pharmacies, with the UK parent entity being Releaf Dispensary Ltd and the German subsidiary being Releaf DE GmbH.

Product overview

Releaf operates a single unified telehealth/mail-order medical cannabis clinic platform with country-specific localisations rather than a distinct platform-plus-modules architecture. The core service — Releaf UK — provides online specialist consultations, prescriptions, and direct-to-patient dispensing of medical cannabis, supported by the AI-powered cannabis strain search and the Releaf Cannabis Card (proof of legal entitlement). Releaf Germany (Releaf DE) is the country-specific localisation of the same core clinic service for the German market, sharing the core prescribing and fulfilment flow. Releaf Protect is an add-on legal-support service offered to patients in partnership with the law firm Irwin Mitchell. Together, the UK and DE services form the core product, while the AI strain search, Cannabis Card, and Releaf Protect function as integrated features/add-on offerings within the same patient journey.

Differentiator

Problem solved

Functional benefit

Brands

• Releaf Protect: 24/7 patient legal support service operated by Releaf in partnership with UK law firm Irwin Mitchell, launched in 2026.

Quantifiable outcome

• 97% of 1,669 surveyed patients reported improved quality of life with cannabis treatment (2025 UK survey)
• +5 more outcomes

Segments9 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability5 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Irwin MitchellflagshipStrategic or Co-development Partner · 1 January 2026Releaf has partnered with UK law firm Irwin Mitchell to launch "Releaf Protect," a 24/7 legal support service for medical cannabis patients. The service helps patients who face employment discrimination, police interaction issues or other legal challenges after disclosing a medical cannabis prescription. Coverage in businessofcannabis (2026-03-06 and 2026-02-06) frames the partnership as a major patient-protection initiative and one of the most substantive service additions from a UK medical cannabis clinic.
• Grafenberger ApothekecoreChannel Partner/ Reseller/ DistributorLicensed German pharmacy at Grafenberger Allee 409, 40235 Düsseldorf, listed as a Releaf DE partner pharmacy on the contact page. Pharmacist-staffed dispensary that fulfills Releaf prescriptions, including specific product lines such as Pedanios 31/1 COS-CA Cosmic Cream. Patients with delivery questions are referred directly to the pharmacy (Phone: 0211 54239220, [email protected]).
• Apotheke am Bahnhof (Speyer)coreChannel Partner/ Reseller/ DistributorSecond German partner pharmacy disclosed on the Releaf DE contact page, located at Bahnhofstraße 49, 67346 Speyer. Fulfills Releaf prescriptions in the Speyer area (Phone: 06232 73132, [email protected]).
• Aurora (Aurora Cannabis Inc.)coreOEM/ Whitelabel/ Licensing PartnerAurora supplies the Pedanios line of medical cannabis products distributed by Releaf DE, including strains like Pedanios 31/1 COS-CA Cosmic Cream, Pedanios 26/1 EHD-CA Electric Honeydew, and Pedanios 10/13 MBE-CA Moon Berry — cultivated in Canada under GMP/GCP conditions with irradiated post-harvest processing.
• CannamedicalcoreOEM/ Whitelabel/ Licensing PartnerCannamedical is a major product supplier for Releaf DE, providing strains such as Cannamedical Sativa forte NM Wedding Tree, Cannamedical Hybrid Forte 24/1 Garlic Truffle, Cannamedical Hybrid Forte DK 24/1 Ghost Train Haze, and Cannamedical Hybrid Forte NM Gorilla Zkittlez — sourced from North Macedonia, Denmark and Canada.
• Dr. AnsayminorOthersListed on Releaf DE's "Wir sind Marktführer" comparison table as a German cannabis competitor (RX fee €14.20, flower from €3.40/g). It is referenced in a competitive context, not as a partnership, so it is included for completeness as an ecosystem peer.
• BloomwellminorOthersListed on Releaf DE's "Wir sind Marktführer" comparison table as a German cannabis competitor (RX fee €25.22, flower from €4.99/g). It is referenced in a competitive context, not as a partnership, so it is included for completeness as an ecosystem peer.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Lyphe Clinic: UK private medical cannabis clinic offering online consultations, prescriptions and pharmacy fulfillment. Directly comparable to Releaf UK in patient base size, indication coverage and D2C digital clinic model.
• Mamedica: UK private medical cannabis clinic prescribing for chronic pain, mental health and neurological conditions via an online consultation model. Closely comparable patient journey, target indications and pricing structure to Releaf UK.
• The Medical Cannabis Clinics: One of the established UK private medical cannabis clinic networks with online consultations and home delivery. Operates in the same regulatory environment and patient segments as Releaf UK.
• CB1 Medical: UK-based medical cannabis clinic with a digital prescribing and pharmacy-fulfillment model targeting chronic pain, anxiety and sleep patients. Directly competes with Releaf for the same private UK patient base.
• Curaleaf Clinic (formerly Kanabo): UK medical cannabis clinic offering online specialist consultations and prescriptions, part of the wider Curaleaf group. Comparable digital clinic model and patient target audience to Releaf UK.
• Bloomwell: Germany-based medical cannabis telehealth platform explicitly benchmarked by Releaf on its own competitive comparison page. Closest direct peer in Germany for online prescriptions, pricing (€25.22 Rx fee) and flower selection.
• Dr. Ansay (Sanity Group): German online cannabis clinic operated by Sanity Group, explicitly listed by Releaf as a benchmark competitor (€14.20 Rx fee, flower from €3.40/g). Direct competitor in the German D2C medical cannabis clinic market.

Broad incumbents

• Cantourage: European medical cannabis distributor and platform that works with multiple clinics and pharmacies across Germany and the UK. Comparable in product breadth and pharma-grade supply chain, though it operates B2B rather than D2C.
• Zerenia Clinics: Multi-country medical cannabis clinic group (UK, Germany, Italy, Colombia) offering specialist consultations and prescriptions. Operates the same D2C clinic model as Releaf but with broader geographic footprint and incumbent scale.

Emerging players

• Sana Healthcare: UK emerging private medical cannabis clinic with a digital consultation workflow. Smaller patient base than Releaf but overlapping indications and target audience, positioning it as a UK emerging peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/releaf_uk
• Facebookfacebook.com/people/Releaf-De/61579073512513
• LinkedInlinkedin.com/company/releafuk
• Instagraminstagram.com/releafde

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Releaf